About ElectroCore
ElectroCore is a publicly listed company based in Basking Ridge (United States) founded in 2005 by JP Errico. Non-invasive vagus nerve stimulation devices are developed for headache treatments. ElectroCore has raised $161.39 million across 14 funding rounds from investors including Core Ventures Group, Merck Global Health Innovation Fund and American Investment Holdings. The company has 73 employees. ElectroCore has completed 1 acquisition, including NeuroMetrix. Its chief executive, as recorded, is Dan Goldberger. Its website electrocore.com draws about 14 thousand monthly visits. ElectroCore offers products and services including gammaCore and gammaCore Sapphire. Its focus areas include Life Sciences, Neurology, Drugs and Diversified. Its legal entity is ELECTROCORE, INC. Its competitors include Kriya Therapeutics, Sana Biotechnology and PureTech Health; 3 of its 3 listed competitors have raised funding.
Company details
ElectroCore was founded in 2005 and is headquartered in Basking Ridge, United States. Non-invasive vagus nerve stimulation devices, including the portable gammaCore, are developed by the company for medical applications. These devices deliver mild electrical signals to address migraines, cluster headaches, epilepsy, gastric motility disorders, depression, and anxiety. Operations focus on neuromodulation technology within the medical device sector.
- Headquarters Basking Ridge, United States
- Employees 73
- Founders JP Errico
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website electrocore.com
- Social LinkedIn X YouTube
- Legal Name Electrocore, Inc.
- Annual Revenue$32.03 M (USD)27.2as on Dec 31, 2025
- Net Profit-$13.97 M (USD)-17.5as on Dec 31, 2025
- EBITDA-$11.48 M (USD)-5.26as on Dec 31, 2025
- Total Equity Funding$161.39M (USD)
in 14 rounds
- Latest Funding Round$1.86M (USD), Post-IPO
Oct 2025
- InvestorsCore Ventures Group
& 4 more
- Employee Count73
- Investments & Acquisitions
Products & Services of ElectroCore
ElectroCore offers a comprehensive portfolio of products and services, including gammaCore and gammaCore Sapphire.
Non-invasive stimulator for treating neurological disorders.
Advanced vagus nerve stimulator for specific health applications.
Apps and channels of ElectroCore
its YouTube channel electroCore: Leaders in Vagus Nerve Stimulation has 481 subscribers and 28 videos.
Videos from ElectroCore
The most watched videos on ElectroCore's YouTube channel, electroCore: Leaders in Vagus Nerve Stimulation (481 subscribers). Click a video to play it here.
Funding Insights of ElectroCore
ElectroCore has successfully raised a total of $161.39M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.86 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $161.39M
- Total Rounds 14
- Last Round Post-IPO — $1.86M
- First Round $500,000
(Nov 2012)
- Investors Count 5
Latest 10 of 14 funding rounds of ElectroCore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $1.86M | Post-IPO | – | – | – |
| Jun 2024 | $7.85M | Post-IPO | – | – | – |
| Aug 2023 | $750,000 | Post-IPO | – | – | – |
| Oct 2021 | $192,000 | Post-IPO | – | – | – |
| May 2020 | $463,678 | Post-IPO | – | – | – |
| May 2020 | $1.55M | Post-IPO | – | – | – |
| Apr 2020 | $1.75M | Post-IPO | – | – | – |
| Aug 2017 | $70.89M | Series B | – | Core Ventures Group | |
| May 2017 | $7.88M | Debt – Conventional | – | – | – |
| Jun 2016 | $1.5M | Debt – Conventional | – | – | – |
5 investors in total: 5 institutional.
Investors in ElectroCore
ElectroCore has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Core Ventures Group, Merck Global Health Innovation Fund and American Investment Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech focused VC firm investing in seed stage startups in the US | coreventuresgroup.com | San Francisco, United States | ||
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
| eastoncapital.com | ||||
| knollcapital.com |
Investor details for ElectroCore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ElectroCore
17 people are tracked at ElectroCore (8 in leadership, 7 in board & advisors, 2 in team); the tracked headcount is 73.
| Name | Role | Group |
|---|---|---|
JP Errico | Founder | Leadership |
Dan Goldberger | CEO | Leadership |
Daniel S. Goldberger | CEO | Leadership |
Peter S. Staats | Chief Medical Officer | Leadership |
Joshua Lev | Chief Strategy Officer | Leadership |
Mitch Deshon | VP, Global Sales & Business Development | Leadership |
Brian Posner | CFO | Leadership |
Carrie Kochek | Senior Director, Human Resources | Leadership |
Peter Cuneo | Chairman | Board & advisors |
Thomas J. Errico | Founder & Principal Investor | Board & advisors |
Michael G. Atieh | Director | Board & advisors |
John Gandolfo | Director | Board & advisors |
Thomas M. Patton | Director | Board & advisors |
Patricia Derrico Wilber | Director | Board & advisors |
Julie Bruzzone-Goldstein | Director | Board & advisors |
Mike Romaniw | EVP, Systems & Operations | Team |
Manny Marques | SVP, Operations | Team |
Complete people profiles for ElectroCore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ElectroCore
ElectroCore is a publicly listed company on the NASDAQ with ticker symbol ECOR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Jun 2018
- Listed onNASDAQ: ECOR
- Listed entityelectroCore, Inc.
- Exchange sectorHealth technology
- ISINUS28531P2020
- Share price$8.39 (-9.59% on the day) · 2026-10-13
- Market capitalisation$75.6M
- EPS (diluted, trailing year)$-1.70
- Volume (last session)184,738
Financials of ElectroCore
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $32.0M | -$14.0M | -$11.5M |
| 2024 | $25.2M | -$11.9M | -$10.9M |
| 2023 | $16.0M | -$18.8M | -$17.6M |
| 2022 | $8.6M | -$22.2M | -$22.3M |
| 2021 | $5.5M | -$17.2M | -$19.7M |
Detailed financial statements for ElectroCore
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ElectroCore
ElectroCore has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NeuroMetrix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Wearable technology for pain, nerve disease and sleep disorders | neurometrix.com | Woburn, United States | 1996 | Dec 2024 | •••• |
Complete acquisition details for ElectroCore
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ElectroCore
5 dated milestones of ElectroCore across 20 years, from founding to its latest funding, stage changes and deals.
- Founded ElectroCore is founded.
- Funding First funding round of $500K.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires NeuroMetrix.
- Funding Latest funding round, Post-IPO, of $1.9M.
Competitors of ElectroCore
ElectroCore has 3 listed competitors in our database, 3 of them funded. They include Kriya Therapeutics, Sana Biotechnology and PureTech Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kriyatherapeutics.com | 2012 | Redwood, United States | $930.93M | 159 | Developer of therapeutic solutions for the treatment of diabetes | |
| sana.com | 2018 | Seattle, United States | $821M | 328 | Genetically engineered cell therapies are developed for multiple disorders. | |
| puretechhealth.com | 2001 | Boston, United States | $107M | 171 | Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases. |
Detailed competitors of ElectroCore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ElectroCore
The website of ElectroCore (electrocore.com) receives about 14K visits a month.
- Monthly visits14K
▲ 48.5% vs previous month
Websites whose visitors overlap most with ElectroCore. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
wheelchairliberty.com | wheelchairliberty.com | 100% | #2,865,989 | – | |
truvaga.com | truvaga.com | 93% | – | ||
chiesi.uk.com | chiesi.uk.com | 50% | #7,981,366 | – |
Top companies in Pain Management
3 companies that operate in the same segment as ElectroCore (Pain Management) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Electrocore
Complete news archive for ElectroCore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ElectroCore
ElectroCore was founded in 2005 and raised its 1st funding round 7 years after it was founded.
ElectroCore is headquartered in Basking Ridge, United States. It is registered at Basking Ridge, New Jersey, United States.
Dan Goldberger is the CEO of ElectroCore, as recorded in our data.
ElectroCore is a funded company, having raised a total of $161.39M across 14 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $1.5M, raised on Nov 2012.
ElectroCore has 73 employees.
Annual revenue of ElectroCore is $32.03M as on Dec 31, 2025.
ElectroCore was founded in 2005 and is headquartered in Basking Ridge, United States. Non-invasive vagus nerve stimulation devices, including the portable gammaCore, are developed by the company for medical applications. These devices deliver mild electrical signals to address migraines, cluster headaches, epilepsy, gastric motility disorders, depression, and anxiety. Operations focus on neuromodulation technology within the medical device sector.
ElectroCore's top competitors include Sana Biotechnology, PureTech Health and Kriya Therapeutics.
ElectroCore offers gammaCore and gammaCore Sapphire.
Yes, ElectroCore is publicly traded on NASDAQ under the ticker symbol ECOR.
ElectroCore has made 1 acquisition, including NeuroMetrix.
ElectroCore has 5 investors. Key investors include Core Ventures Group, Merck Global Health Innovation Fund, American Investment Holdings, Knoll Capital Management, and Easton Capital Investment Group.